Archive for November 2022

Norm Laviolette may come to baseball with a long resume in comedy and entertainment, but he’s ready to blend the two. Read More

As CEOs like Elon Musk bring employees back to the office to cope with challenging circumstances, new data shows hybrid work hasn’t lost its luster among employees. Here’s what businesses need to know. Read More

David Jiménez, a multidecade veteran of Johnson & Johnson who was most recently president of the Janssen immunology division, has joined Moderna to oversee U.S. commercial operations. Read More

By the deadline of 2 p.m. Monday, the Mass. Gaming Commission received 15 total sports betting operator applications including just six applications for the seven available mobile-only betting licenses, the commission said. Read More

A little more than a year since its acquisition by AstraZeneca plc, Alexion Pharmaceuticals Inc. is operating in "the best of both worlds" as the official rare disease unit of the U.K. pharma giant. Read More

Pegasystems Inc. is reportedly in talks to get a $1 billion investment at a time the enterprise software maker is in the middle of a $2 billion lawsuit with Appian Corp. Read More

The proposal for the 1.28-million-square-foot facility had prompted a lawsuit and vocal opposition from neighbors. Read More

Northeastern University has named two new trustees to its board who both graduated from the school’s new campus at Mills College in Oakland. Read More

The Massachusetts Democrat and other lawmakers cited bitcoin’s plummeting price and FTX’s collapse. Read More

Gen Z is the most diverse generation to enter the American workforce, but experts say that’s just one of the reasons it’s a pivotal ingredient for recruiting, retaining and connecting with Gen Z. Read More